Dong-A Socio Holdings Overview
- Year Founded
-
1932
- Status
-
Public
- Employees
-
82
- Stock Symbol
-
000640
- Investments
-
12
- Share Price
-
$88.10
- (As of Friday Closing)
Dong-A Socio Holdings General Information
Description
Dong-A Socio Holdings Co Ltd is a pharmaceutical company. The company is engaged in the development of biomedicines and innovative drugs, and to expand businesses from pharmaceuticals to medical services and new businesses.
Contact Information
Website
www.donga.co.krCorporate Office
- 64 Cheonho-daero
- Seoul, Dongdaemun 02587
- South Korea
Corporate Office
- 64 Cheonho-daero
- Seoul, Dongdaemun 02587
- South Korea
Dong-A Socio Holdings Stock Performance
As of 13-Jun-2025, Dong-A Socio Holdings’s stock price is $88.10. Its current market cap is $567M with 6.44M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $88.10 | $86.01 | $62.11 - $93.55 | $567M | 6.44M | 12.4K | $7.64 |
Dong-A Socio Holdings Financials Summary
As of 31-Mar-2025, Dong-A Socio Holdings has a trailing 12-month revenue of $973M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 843,074 | 891,583 | 876,082 | 810,927 |
| Revenue | 972,609 | 977,128 | 865,810 | 785,424 |
| EBITDA | 63,825 | 139,901 | 121,052 | 77,966 |
| Net Income | 48,788 | 42,525 | 44,353 | 8,631 |
| Total Assets | 1,399,467 | 1,378,495 | 1,518,691 | 1,371,002 |
| Total Debt | 507,529 | 502,362 | 536,892 | 437,192 |
Dong-A Socio Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Dong-A Socio Holdings Comparisons
Industry
Financing
Details
Dong-A Socio Holdings Competitors (33)
One of Dong-A Socio Holdings’s 33 competitors is Sun Pharmaceutical Industries, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Corporation | Mumbai, India | ||||
| Sagent Pharmaceuticals | Formerly VC-backed | Schaumburg, IL | ||||
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Abbott India | Corporation | Mumbai, India | ||||
| GSK | Corporation | London, United Kingdom |
Dong-A Socio Holdings Patents
Dong-A Socio Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3603669-A1 | Aqueous formulation, aqueous formulation in injector, antibody protein disaggregating agent, and antibody protein disaggregation method | Active | 31-Mar-2017 | ||
| EP-3603669-A4 | Aqueous formulation, aqueous formulation in injector, antibody protein disaggregating agent, and antibody protein disaggregation method | Active | 31-Mar-2017 | ||
| US-20200093927-A1 | Aqueous formulation and in-syringe aqueous formulation, and antibody protein deaggregation agent and antibody protein deaggregation method | Inactive | 31-Mar-2017 | ||
| EP-3603669-B1 | Aqueous formulation, aqueous formulation in injector, antibody protein disaggregating agent, and antibody protein disaggregation method | Active | 31-Mar-2017 | ||
| ES-2986026-T3 | Aqueous formulation, aqueous formulation in injector, antibody protein disaggregating agent and antibody protein disaggregation method | Active | 31-Mar-2017 | A61K39/39591 |
Dong-A Socio Holdings Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Dong-A Socio Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Dong-A Socio Holdings Investments & Acquisitions (12)
Dong-A Socio Holdings’s most recent deal was a Early Stage VC with MEPSGEN for . The deal was made on 13-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MEPSGEN | 13-Jul-2022 | Early Stage VC | Drug Discovery | ||
| Mezoo | 25-Nov-2021 | Later Stage VC | Monitoring Equipment | ||
| Medical IP | 21-Jun-2021 | Later Stage VC | Decision/Risk Analysis | ||
| Stgen Bio | 01-Jan-2021 | Merger/Acquisition | BPO/Outsource Services | ||
| Intake (Food Products) | 31-Dec-2020 | Later Stage VC | Food Products |
Dong-A Socio Holdings ESG
Risk Overview
Risk Rating
Updated November, 02, 2024
29.67 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,673
Rank
Percentile
Pharmaceuticals
Industry
of 844
Rank
Percentile
Pharmaceuticals
Subindustry
of 419
Rank
Percentile
Dong-A Socio Holdings FAQs
-
When was Dong-A Socio Holdings founded?
Dong-A Socio Holdings was founded in 1932.
-
Where is Dong-A Socio Holdings headquartered?
Dong-A Socio Holdings is headquartered in Seoul, South Korea.
-
What is the size of Dong-A Socio Holdings?
Dong-A Socio Holdings has 82 total employees.
-
What industry is Dong-A Socio Holdings in?
Dong-A Socio Holdings’s primary industry is Pharmaceuticals.
-
Is Dong-A Socio Holdings a private or public company?
Dong-A Socio Holdings is a Public company.
-
What is Dong-A Socio Holdings’s stock symbol?
The ticker symbol for Dong-A Socio Holdings is 000640.
-
What is the current stock price of Dong-A Socio Holdings?
As of 13-Jun-2025 the stock price of Dong-A Socio Holdings is $88.10.
-
What is the current market cap of Dong-A Socio Holdings?
The current market capitalization of Dong-A Socio Holdings is $567M.
-
What is Dong-A Socio Holdings’s current revenue?
The trailing twelve month revenue for Dong-A Socio Holdings is $973M.
-
Who are Dong-A Socio Holdings’s competitors?
Sun Pharmaceutical Industries, Sagent Pharmaceuticals, Zydus Lifesciences, Abbott India, and GSK are some of the 33 competitors of Dong-A Socio Holdings.
-
What is Dong-A Socio Holdings’s annual earnings per share (EPS)?
Dong-A Socio Holdings’s EPS for 12 months was $7.64.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
